Search Results - "Deo, MG"

Refine Results
  1. 1
  2. 2

    Prevalence and risk factors of hypertension and diabetes in the Katkari tribe of coastal Maharashtra by Deo, MG, Pawar, PV, Kanetkar, SR, Kakade, SV

    Published in Journal of postgraduate medicine (Bombay) (01-04-2017)
    “…Background and Objectives: Urban and rural India are both going through health epidemiological transition and will soon face huge burden of noncommunicable…”
    Get full text
    Journal Article
  3. 3

    Multicentric study on prevalence and risk factors for hypertension and diabetes in tribal communities in Western and Northern Maharashtra by Deo, M, Pawar, P, Kanetkar, S, Kakade, S

    Published in Journal of postgraduate medicine (Bombay) (01-01-2018)
    “…Background and Objectives: Although a number of studies have been conducted on the prevalence of hypertension (HTN) and diabetes on tribal populations in…”
    Get full text
    Journal Article
  4. 4

    High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India by SARANATH, D, CHANG, S. E, BHOITE, L. T, PANCHAL, R. G, KERR, I. B, MEHTA, A. R, JOHNSON, N. W, DEO, M. G

    Published in British journal of cancer (01-04-1991)
    “…57 primary tumour samples from Indian oral cancer patients with a 5-15 year tobacco chewing habit, were examined for mutational activation in codons 12, 13 and…”
    Get full text
    Journal Article
  5. 5

    Undergraduate medical students' research in India by Deo, MG

    Published in Journal of postgraduate medicine (01-07-2008)
    “…The enthusiasm exhibited by the delegates of the two National Medical Students' Research Conferences held in Pune under the banner of the Moving Academy of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Enhancing factor, a Paneth cell specific protein from mouse small intestines: predicted amino acid sequence from RT-PCR amplified cDNA and its expression by Mulherkar, R, Rao, R S, Wagle, A S, Patki, V, Deo, M G

    “…Enhancing factor (EF), a Paneth cell specific growth factor modulator, has been identified in our laboratory from mouse small intestines. In this paper we…”
    Get more information
    Journal Article
  8. 8

    Establishment of a human squamous cell carcinoma cell line of the upper aero-digestive tract by Mulherkar, Rita, Goud, Anuradha P., Wagle, Archana S., Naresh, K.N., Mahimkar, Manoj B., Thomas, Sufi M., Pradhan, S.A., Deo, M.G.

    Published in Cancer letters (16-09-1997)
    “…A human squamous cell carcinoma (SCC) cell line has been established from the surgical specimen of an untreated, upper aero-digestive tract tumour, diagnosed…”
    Get full text
    Journal Article
  9. 9

    Leprosy vaccine by Deo, M. G

    Published in Nature (London) (09-06-1994)
    Get full text
    Journal Article
  10. 10

    Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India by Fernandez, T, Saranath, D, Advani, S.H, Deo, M.G, Soman, C.S

    Published in Cancer letters (13-03-1998)
    “…We examined 89 non-Hodgkin's lymphoma (NHL) patients of Indian origin for EcoRI restriction fragment length polymorphism (RFLP) of the L-myc gene with a view…”
    Get full text
    Journal Article
  11. 11

    Oncogene Amplification in Squamous Cell Carcinoma of the Oral Cavity by Saranath, Dhananjaya, Panchal, Rekha G., Nair, Rama, Mehta, Ashok R., Sanghavi, Vikram, Sumegi, Janos, Klein, George, Deo, Madhav G.

    Published in Japanese Journal of Cancer Research (01-05-1989)
    “…We have determined the prevalence of amplification of c‐myc, N‐myc, L‐myc, H‐ras, Ki‐ras, and N‐ras oncogenes in 23 cases of squamous cell carcinoma of the…”
    Get full text
    Journal Article
  12. 12

    Enhancing factor protein from mouse small intestines belongs to the phospholipase A2 family by Mulherkar, Rita, Rao, Renuka, Rao, Laxmi, Patki, Varsha, Chauhan, V.S., Deo, Madhav G.

    Published in FEBS letters (15-02-1993)
    “…Enhancing factor (EF), a growth regulatory molecule, isolated from mouse small intestines, has been well characterized in this laboratory. It increases the…”
    Get full text
    Journal Article
  13. 13

    Loss of p53 gene as a biomarker of high risk oral leukoplakias by Saranath, D, Tandle, A T, Deo, M G, Mehta, A R, Sanghvi, V

    “…We have investigated loss of heterozygosity of p53 tumor suppressor gene in Indian oral cancer patients, individuals with premalignant leukoplakia lesions, and…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Restriction fragment length polymorphism of the L-myc gene in oral cancer patients by SARANATH, D, PANCHAL, R. G, NAIR, R, MEHTA, A. R, SANGHAVI, V, DEO, M. G

    Published in British journal of cancer (01-04-1990)
    “…Restriction fragment length polymorphism (RFLP) of the L-myc gene was examined in DNAs from primary tumour tissues and peripheral blood cells (PBC) of 76…”
    Get full text
    Journal Article
  16. 16

    ICRC 'anti-leprosy vaccine' by Deo, M G

    Published in Vaccine (01-04-1989)
    “…A vaccine containing ICRC bacilli, which are leprosy-derived cultivable mycobacteria, induces lepromin conversion in LL patients and lepromin-negative persons…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas by DHANANJAYA SARANATH, BHOITE, L. T, MEHTA, A. R, VIKRAM SANGHAVI, DEO, M. G

    “…The Harvey ras locus was examined for restriction fragment polymorphism and loss of allelic heterozygosity in 62 oral cancer patients. Southern blot analysis…”
    Get full text
    Journal Article
  19. 19

    ICRC mouse with congenital mega-esophagus as a model to study esophageal tumorigenesis by Ghaisas, S, Saranath, D, Deo, M G

    Published in Carcinogenesis (New York) (01-10-1989)
    “…ICRC mouse, an inbred strain, developed at the Cancer Research Institute, Bombay, exhibits mega-esophagus with markedly hyperplastic mucosa. Diethylnitrosamine…”
    Get more information
    Journal Article
  20. 20